Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11046691
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors
granted -
US 11046755
Antibody based reagents that specifically recognize toxic oligomeric forms of tau
granted -
US 11046670
Piperazinyl norbenzomorphan compounds and methods for using the same
granted -
SG 11202104918P
THERAPY FOR TREATING CANCER WITH AN INTRATUMORAL AND/OR INTRAVENOUS ADMINISTRATION OF A RECOMBINANT MVA ENCODING 4-1BBL (CD137L) AND/OR CD40L
granted -
US 11045493
Synthetic melanin nanoparticles and uses thereof
granted -
US 11045558
RPGR gene therapy for retinitis pigmentosa
granted -
US 11045453
Serine protease inhibitor for treating coronavirus infection
granted -
US 2021186075
COMPOSITIONS COMPRISING BACTERIAL STRAINS FOR USE IN INCREASING THE BIOAVAILABILITY OF AMINO ACIDS DERIVED FROM PROTEINS, AND RELATED FOOD PRODUCT METHODS AND SYSTEMS
granted -
US 11041008
Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia
granted -
US 11040029
Methods for the administration of certain VMAT2 inhibitors
granted -
US 11040107
Dosing regimens and related compositions and methods
granted -
US 11040070
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 11040084
Stable antibody-drug conjugate, preparation method therefor, and use thereof
granted -
US 11040998
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
granted -
US 11041202
Method of identifying human compatible T cell receptors specific for an antigenic target
granted -
US 11040091
Cycle adenosine monophosphate-incompetent adenylyl cyclase and compositions and methods for treating heart failure and increasing cardiac function
granted -
US 11041205
Molecular targets for ALS and related disorders
granted -
US 11041174
Compositions for linking DNA-binding domains and cleavage domains
granted -
US 11041170
Multivalent vaccines for rabies virus and coronaviruses
granted -
US 11041149
PH20 polypeptide variants, formulations and uses thereof
granted -
US 11041023
Chimeric antigen receptors for phagocytosis
granted -
US 11041000
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
granted -
US 11040984
Quinazoline compound for EGFR inhibition
granted -
US 11040959
Diprovocims: a new and potent class of TLR agonists
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.